Substituted quinazolin-4-ylamine analogues are provided. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.

 
Web www.patentalert.com

< Method for enhancing the bioavailability of ospemifene

< Heteroaryl compounds as P2Y1 receptor inhibitors

> Compounds for inflammation and immune-related uses

> Modulators of TNF-alpha signaling

~ 00280